These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 9161625)
1. Adverse drug reactions in home care patients receiving nafcillin or oxacillin. Dahlgren AF Am J Health Syst Pharm; 1997 May; 54(10):1176-9. PubMed ID: 9161625 [TBL] [Abstract][Full Text] [Related]
2. Higher occurrence of hepatotoxicity and rash in patients treated with oxacillin, compared with those treated with nafcillin and other commonly used antimicrobials. Maraqa NF; Gomez MM; Rathore MH; Alvarez AM Clin Infect Dis; 2002 Jan; 34(1):50-4. PubMed ID: 11731945 [TBL] [Abstract][Full Text] [Related]
3. Adverse effects of methicillin, nafcillin and oxacillin in pediatric patients. Nahata MC; DeBolt SL; Powell DA Dev Pharmacol Ther; 1982; 4(3-4):117-23. PubMed ID: 7172968 [TBL] [Abstract][Full Text] [Related]
4. Adverse Events Lead to Drug Discontinuation More Commonly among Patients Who Receive Nafcillin than among Those Who Receive Oxacillin. Viehman JA; Oleksiuk LM; Sheridan KR; Byers KE; He P; Falcione BA; Shields RK Antimicrob Agents Chemother; 2016 May; 60(5):3090-5. PubMed ID: 26976858 [TBL] [Abstract][Full Text] [Related]
5. Disproportionality Analysis of Safety with Nafcillin and Oxacillin with the FDA Adverse Event Reporting System (FAERS). Timbrook TT; McKay L; Sutton JD; Spivak ES Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844017 [TBL] [Abstract][Full Text] [Related]
6. Patient Variables Associated with Nafcillin Plasma Concentrations and Toxicity. Benefield RJ; Barker BC; Gast CM; Alexander DP Pharmacotherapy; 2016 Sep; 36(9):994-1002. PubMed ID: 27485941 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the efficacy and safety of outpatient parenteral antimicrobial therapy for infections with methicillin-sensitive Staphylococcus aureus. Wynn M; Dalovisio JR; Tice AD; Jiang X South Med J; 2005 Jun; 98(6):590-5. PubMed ID: 16004164 [TBL] [Abstract][Full Text] [Related]
9. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Jose J; Rao PG Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163 [TBL] [Abstract][Full Text] [Related]
10. Anti-infectives-induced adverse drug reactions in hospitalized patients. Gholami K; Parsa S; Shalviri G; Sharifzadeh M; Assasi N Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):501-6. PubMed ID: 15844215 [TBL] [Abstract][Full Text] [Related]
11. Monitoring drug safety in Astrakhan, Russia. Kirilochev OO; Dorfman IP; Umerova AR Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley. Jha N; Bajracharya O; Namgyal T Kathmandu Univ Med J (KUMJ); 2007; 5(4):504-10. PubMed ID: 18604084 [TBL] [Abstract][Full Text] [Related]
13. A prospective study of adverse drug reactions in a dermatology department. Ganeva M; Gancheva T; Lazarova R; Tzvetanova Y; Hristakieva E Methods Find Exp Clin Pharmacol; 2007 Mar; 29(2):107-12. PubMed ID: 17440627 [TBL] [Abstract][Full Text] [Related]
14. Frequency of drug-induced liver injury in children receiving anti-staphylococcal penicillins. Tang K; Coombs S; Gwee A J Antimicrob Chemother; 2022 Nov; 77(12):3221-3230. PubMed ID: 36203386 [TBL] [Abstract][Full Text] [Related]
15. Developing an adverse drug reaction reporting system at a teaching hospital. Baniasadi S; Fahimi F; Shalviri G Basic Clin Pharmacol Toxicol; 2008 Apr; 102(4):408-11. PubMed ID: 18312492 [TBL] [Abstract][Full Text] [Related]
16. Adverse reactions to methicillin and nafcillin during treatment of serious Staphylococcus aureaus infections. Kancir LM; Tuazon CU; Cardella TA; Sheagren JN Arch Intern Med; 1978 Jun; 138(6):909-11. PubMed ID: 646562 [TBL] [Abstract][Full Text] [Related]
17. Adverse drug reactions in Nigerian children: a retrospective review of reports submitted to the Nigerian Pharmacovigilance Centre from 2005 to 2012. Obebi Cliff-Eribo K; Sammons H; Star K; Ralph Edwards I; Osakwe A; Choonara I Paediatr Int Child Health; 2016 Nov; 36(4):300-304. PubMed ID: 26384567 [TBL] [Abstract][Full Text] [Related]
18. Adverse drug reactions experience in a teaching hospital in Jordan. Alsbou M; Alzubiedi S; Alzobi H; Samhadanah NA; Alsaraireh Y; Alrawashdeh O; Aqel A; Al-Salem K Int J Clin Pharm; 2015 Dec; 37(6):1188-93. PubMed ID: 26286340 [TBL] [Abstract][Full Text] [Related]
19. Pediatric pharmacovigilance in an institute of national importance: Journey has just begun. Sharma PK; Misra AK; Gupta N; Khera D; Gupta A; Khera P Indian J Pharmacol; 2017; 49(5):390-395. PubMed ID: 29515280 [TBL] [Abstract][Full Text] [Related]
20. [Treatment with other penicillins in proven penicillin allergy?]. Pevny I; Hartmann K; Schröpl F Dtsch Med Wochenschr; 1973 Aug; 98(35):1597-600. PubMed ID: 4200359 [No Abstract] [Full Text] [Related] [Next] [New Search]